Saturday, March 2, 2024

CATEGORY

Certa Therapeutics

FT011: A Pioneering Oral Therapy for Multiple Organ Fibrosis

FT011, an innovative first-in-class oral therapy, is under clinical development for the treatment of scleroderma. This drug is designed to treat chronic fibrosis across...

Latest news

Sticky Image